Loading...

HAEMOPHILIA (F8 & F9) GENE PANEL BY NGS, EDTA BLOOD

image not found

 NABL Cap Accredited 
The Haemophilia (F8 & F9) Gene Panel by NGS focuses on detecting mutations in the F8 and F9 genes, which are responsible for haemophilia A and haemophilia B. Using an EDTA blood sample, this test identifies variants affecting clotting factor production and bleeding tendency. Metropolis Healthcare uses advanced next-generation sequencing to ensure high accuracy and reliable mutation detection. The results support precise diagnosis, family screening, and personalized treatment planning

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 19,950.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes:G0202

Frequently Asked Questions (FAQ's):

 What does the Haemophilia (F8 & F9) Gene Panel include at Metropolis Healthcare?

It analyzes the F8 and F9 genes associated with haemophilia A and B using high-quality next-generation sequencing.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare extracts DNA from EDTA blood and sequences the F8 and F9 genes using advanced NGS technology for accurate variant detection.

Who should consider taking this test at Metropolis Healthcare?
Individuals with prolonged bleeding, easy bruising, low clotting factor levels, or a family history of haemophilia may benefit from this panel.

What sample is required for this test at Metropolis Healthcare?
A routine EDTA blood sample is sufficient for precise genetic sequencing.

How long does Metropolis Healthcare take to deliver the results?
Turnaround time depends on sequencing and analysis steps, with reports provided promptly after evaluation.

Why choose Metropolis Healthcare for this genetic panel?
Metropolis Healthcare offers accurate sequencing, stringent quality control, and meaningful clinical interpretation specific to haemophilia.

Does Metropolis Healthcare provide support after test results?
Yes, expert genetic insights accompany the report to guide clinicians in diagnosis and treatment planning.

Is this test suitable for children at Metropolis Healthcare?
Yes, the panel is appropriate for both pediatric and adult patients when haemophilia is suspected

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab